Largest ever molecular map of autism opens new paths to precision therapies

Key Points:

• Researchers at UCSF have created the largest molecular interaction map for autism, identifying over 1,800 protein-protein interactions linked to 100 autism risk genes, with 87% previously unknown, revealing how diverse genetic mutations converge on shared protein networks.
• The study shows that many genetically distinct forms of autism disrupt common protein complexes, suggesting the potential for developing therapies targeting these shared molecular hubs rather than individual mutations, which could benefit multiple patient groups simultaneously.
• Disease-causing mutations in autism do not simply break genes but rewire protein interaction networks in predictable ways, with examples like FOXP1 and FOXP2 mutations converging on the same disrupted protein interaction, leading to altered brain development.
• By integrating protein interaction maps with AI-driven structural predictions, researchers pinpointed exact mutation sites disrupting protein interfaces, opening new avenues for drug development aimed at stabilizing or blocking specific protein interactions.
• This research establishes a framework for precision medicine that connects genetic mutations to protein networks and therapeutic targets, offering a blueprint applicable beyond autism to other complex diseases such as neurodegeneration and cancer.